Stockreport

Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead [Seeking Alpha]

Abeona Therapeutics Inc.  (ABEO) 
Last abeona therapeutics inc. earnings: 3/16 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.abeonatherapeutics.com
PDF Zevaskyn's commercial launch is delayed to 4Q25 due to FDA assay requirements, but demand and payer coverage remain robust, aided by a new CMS J-code. ABEO's financia [Read more]